CRISPR-Based Diagnostics of Kidney Disease: Applications in Transplantation and Disease Detection

Explore a 17-minute webinar presentation by clinician-scientist Michael M. Kaminski delving into innovative CRISPR-based diagnostic technologies for kidney disease detection. Learn about CrisprZyme technology, which combines CRISPR/Cas reactions with nanozymes and catalytic metallic nanoparticles for enhanced biomarker detection. Discover how these cutting-edge diagnostic tools offer rapid, highly sensitive detection methods suitable for point-of-care applications, particularly in transplantation medicine, heart disease, and cancer. Drawing from his extensive experience as the leader of an Emmy Noether Research Group at the Berlin Institute of Medical Systems Biology and his clinical practice at Charité – Universitätsmedizin, Dr. Kaminski shares insights into developing novel therapeutic strategies and disease detection methodologies using CRISPR-based tools within the context of kidney disorders.